Biopharmaceutical The reason why this industry is called the eternal sunrise industry is because it is close to the length of human life and people's lives cannot be separated from it. At the same time, the biopharmaceutical industry is also one of the main directions of scientific and technological innovation and competition. The country attaches great importance to the development of the biopharmaceutical industry and the market size continues to expand.
At present, the aging problem of my country's population is becoming more and more serious, and the people's demand for healthy life is becoming increasingly greater, which has directly promoted the development of the biopharmaceutical industry. Excellent enterprises in the industry have carried out new drug research and development activities, accelerating the development of my country's medical innovation capabilities.
Kelaiying
is my country's leading provider of innovative drug CDMO solutions and the world's fifth largest innovative drug CDMO company. It can provide high-quality R&D and production services to domestic and foreign pharmaceutical companies and biotechnology companies.
company has strong R&D capabilities, sufficient orders, and strong certainty in performance.
Kanglong Huacheng
is an internationally leading drug research and development and production enterprise. Its business segments include laboratory chemistry, drug safety evaluation , preparation process development, clinical research services, etc., and ranks second in the domestic similar industry in the field of drug discovery.
is currently actively acquiring high-quality targets to improve the synergy and scale effects between business segments, and create a full-process, integrated drug research and development platform.
Haizheng Pharmaceutical
Company is one of the largest antibiotic and anti-tumor drug manufacturers in my country. It actively improves the independent research and development capabilities and clinical capabilities of innovative drugs. At the same time, the company has made layouts in new fields such as new traditional Chinese medicine and innovative medicine, improving the industrial chain, improving the internal management level, reasonably controlling costs, and improving the profitability of the company.
article content is only personal opinion and is not used as investment advice or basis for trading.
